Originally posted on June 24, 2002

 

In this commentary, Alex Tabarrok of George Mason comments on an idea to introduce innovation and reduce the cost of drugs. Pulling from a paper by Michael Kremer, he outlines the reasoning behind patent buyouts and how they could be used effectively to help put good ideas in the hands of the public.